Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2017/18 group results

May 14 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR      
                   LATEST         YEAR-AGO        COMPANY       COMPANY   
                   RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales            280.09          279.77         269.00        132.00    
                 (+0.1 pct)      (-3.6 pct)     (-4.0 pct)    (-4.8 pct)  
  Operating         36.98           31.97          33.00         14.00    
                 (+15.7 pct)     (+10.7 pct)    (-10.8 pct)   (-7.8 pct)  
  Recurring         42.14           38.04          39.50         16.50    
                 (+10.8 pct)     (+3.4 pct)     (-6.3 pct)    (-7.6 pct)  
  Net
  Net               31.68           28.78          55.50         39.00    
                 (+10.1 pct)     (+28.1 pct)    (+75.2 pct)  (+224.6 pct) 
  EPS            396.54 yen      360.18 yen     694.62 yen    488.10 yen  
  EPS Diluted    396.20 yen      359.92 yen                               
  Ann Div        110.00 yen      110.00 yen     110.00 yen                
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen                
  -Q4 Div         60.00 yen       60.00 yen      60.00 yen                
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news